One reason I still really like $OSCR is that the thesis does not need to be complicated. Oscar does not need to reinvent healthcare. It needs to keep growing, price its plans well, and become more efficient as it gets bigger. Q2 gave us a pretty good look at what that can turn into: MLR improved to 79.2% from 91.1%, SG&A fell to 14.2% from 18.7%, and operating income swung from a $230M loss to a $389M profit YoY. Some of that quarter was helped by favorable reserve development, so I’m not assuming those numbers are the new normal. But if the underlying economics keep moving in this direction, $OSCR could look like a VERY different business a few years from now.
140 views
3 Comments
Nate
@hoodnate · 2m
love a thesis that doesnt need to be complicated. still learning what mlr actually measures
Leo
@l3onel · 2h
Id say nbis
Kornel
@dividendfund · 2h
Im thinking of starting a position in Oscar and NBIS idk what would be better
See the full comment section 👀Sign up for the full Blossom experience!
